Recent Company News

• 03:30 PM ET Jul 08, 2026
  

  CONSOB approves Respighi BidCo's offer document in connection with acquisition of Recordati (€51.60, 0.00)

• 03:10 AM ET Jun 25, 2026
  

  Recordati enters into license agreement with Ionis Pharmaceuticals, Inc. for exclusive development and commercialization rights to Zilganersen (€51.55, 0.00)

• 02:56 AM ET May 13, 2026
  

  StreetAccount Summary - European pre-market trading update

• 11:15 AM ET May 26, 2026
  

  StreetAccount M&A Summary: Week of 18-May

• 01:30 AM ET May 22, 2026
  

  CVC Fund IX and Groupe Bruxelles Lambert announce €51.29/share offer for Recordati in a deal valued €10.7B (€51.70, 0.00)

• 09:29 AM ET May 13, 2026
  

  Transcript Intelligence: Recordati Q1 Earnings Guidance

• 09:29 AM ET May 13, 2026
  

  Transcript Intelligence: Recordati Q1 Earnings Themes

• 09:29 AM ET May 13, 2026
  

  Transcript Intelligence: Recordati Q1 Earnings Q&A